Nick Smith

Nick Smith joined Alto with more than 10 years of experience within central nervous system (CNS)-focused biopharmaceutical companies. Nick brings a broad set of expertise across business development, capital raising, commercial and portfolio strategy, and corporate finance. Most recently, Nick was Vice President of Corporate Development and Investor Relations at Aptinyx, where he was involved in raising more than $300 million across private and public financings and played a key role in the company's IPO. Prior to Aptinyx, Nick worked for Lundbeck serving in roles of increasing responsibility across business development, forecasting, commercial assessment, new product planning, market research, and financial planning and analysis. He received a BA, ACCPA, in accounting and finance from North Central College in Naperville, Illinois.